Thomas G. Wiggans - Nov 28, 2023 Form 4 Insider Report for Jasper Therapeutics, Inc. (JSPR)

Role
Director
Signature
By: /s/ Herb Cross, as Attorney-in-Fact
Stock symbol
JSPR
Transactions as of
Nov 28, 2023
Transactions value $
$6,486
Form type
4
Date filed
11/30/2023, 04:05 PM
Previous filing
Nov 22, 2023
Next filing
Jan 26, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction JSPR Voting Common Stock Purchase $6.49K +10K +25% $0.65 50K Nov 28, 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.6311 to $0.669, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer full information regarding the number of shares purchased or sold at each separate price.